Additional Information
Product Name | Kenalog-40 40 mg/mL Multi-Dose Vial, 5 mL |
Manufacturer Name | Bristol Myers |
Manufacturer # | 00003-0293-20 |
Dosage Form | Injection Suspension |
Application | Intramuscular and Intra-articular only |
Strength | 40 mg/mL |
Sterility | Sterile |
Volume | 5 ml, multiple-dose vial |
pH Adjustment | pH adjusted to 5.0 to 7.5 |
Preservative | Benzyl alcohol |
Air Replacement | Nitrogen |
Storage conditions | Room temperature (20°-25°) |
Description
Kenalog-40 40 mg/mL Multi-Dose Vial, 5 mL is a pharmaceutical product manufactured by Bristol Myers, bearing the Manufacturer # 00003-0293-20. It is an injectable suspension containing triamcinolone acetonide, a synthetic glucocorticoid corticosteroid renowned for its potent anti-inflammatory properties.
This formulation is specifically designed for intramuscular and intra-articular administration, and it is not intended for intradermal injection. Each milliliter (mL) of the sterile aqueous suspension provides 40 milligrams (mg) of triamcinolone acetonide. The suspension is isotonic due to the inclusion of 0.66% sodium chloride.
It contains 0.99% (w/v) benzyl alcohol serving as a preservative, 0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80. The pH of the suspension is adjusted to fall within the range of 5.0 to 7.5, which may involve the presence of sodium hydroxide or hydrochloric acid.